27 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
in Registrant’s Certifying Accountant
Item 16G.
Corporate Governance
Item 16H.
Mine Safety Disclosure
Item 16I.
Disclosure Regarding Foreign Jurisdictions … is required to devote substantial time to corporate governance standards. Also, as a public company we are subject to the requirements of the exchanges on which
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
in Registrant’s Certifying Accountant
Item 16G.
Corporate Governance
Item 16H.
Mine Safety Disclosure
Item 16I.
Disclosure Regarding Foreign Jurisdictions … is required to devote substantial time to corporate governance standards. Also, as a public company we are subject to the requirements of the exchanges
424B5
XRTX
XORTX Therapeutics Inc
29 Nov 23
Prospectus supplement for primary offering
9:57pm
material terms and conditions of the Units.
CORPORATE GOVERNANCE
Under the BCBCA, we are required to hold a general meeting of our shareholders
6-K
EX-99.1
5w5s tdcxou9
29 Jun 23
XORTX Announces Results of Annual and Special Meeting of Shareholders
8:02am
6-K
EX-99.2
hoe2iwz5 164
30 May 23
Notice of Annual & Special Meeting of Shareholders
7:00am
6-K
EX-99.3
5jk hzewh
3 Apr 23
Consolidated Financial Statements
6:05am
424B4
67kvxpjymi5
5 Oct 22
Prospectus supplement with pricing info
5:24pm
POS AM
6rh 04i2e
29 Sep 22
Prospectus update (post-effective amendment)
9:49pm
F-1/A
hb4wjg
21 Sep 22
Registration statement (foreign) (amended)
4:20pm
F-1
nbr510ck
8 Sep 22
Registration statement (foreign)
1:02pm
DRS
ujlrxt dls
15 Aug 22
Draft registration statement
12:00am
6-K
EX-99.2
wxo2ge
30 Jun 22
Notice of Annual & Special Meeting of Shareholders
6:00am
20-F
z5ps2bi u1qcvu8htw9e
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-4.17
85u5w7
3 May 22
Annual report (foreign)
5:29pm
6-K
EX-99.1
1adr6y 52ti4viswv
13 Apr 22
Current report (foreign)
7:23am
6-K
EX-99.2
eukeelcz
23 Nov 21
Notice of Annual & Special Meeting of Shareholders
7:17am